Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes

被引：0
|
作者：
Özlem Seçilmiş Kerimoğlu
Cihangir Mutlu Ercan
Uğur Keskin
Cem Korkmaz
Namık Kemal Duru
Ali Ergün
机构：
[1] Selçuk University Medicine Faculty,Department of Obstetrics and Gynecology
[2] Gülhane Military Medicine Faculty,Department of Obstetrics and Gynecology
[3] Gülhane Military Medicine Faculty,Department of Histology and Embryology
来源：
Archives of Gynecology and Obstetrics | 2013年 / 288卷
关键词：
Antagonist; Cetrorelix; In vitro fertilization; LH surge;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 695
页数：4
相关论文
共 50 条
  • [21] Optimizing assisted reproduction: impact of low-dose gonadotropin-releasing hormone agonist on in vitro fertilization outcome
    Lenton, E
    Mohamed, K
    FERTILITY AND STERILITY, 2005, 84 (06) : 1783 - 1785
  • [22] The role of gonadotropin-releasing hormone antagonists in in vitro fertilization
    Diedrich, K
    Ludwig, M
    Felberbaum, RE
    SEMINARS IN REPRODUCTIVE MEDICINE, 2001, 19 (03) : 213 - 220
  • [23] Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs
    Orvieto, Raoul
    Kruchkovich, Jenny
    Rabinson, Jacob
    Zohav, Efraim
    Anteby, Eyal Y.
    Meltcer, Simion
    FERTILITY AND STERILITY, 2008, 90 (01) : 228 - 230
  • [24] Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome
    Segal, Shimon
    Glatstein, Isaac
    McShane, Patricia
    Hotamisligil, Selen
    Ezcurra, Diego
    Carson, Ronald
    FERTILITY AND STERILITY, 2009, 91 (05) : 1755 - 1759
  • [25] Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes
    Weitzman, Vanessa N.
    Engmann, Lawrence
    DiLuigi, Andrea
    Maier, Donald
    Nulsen, John
    Benadiva, Claudio
    FERTILITY AND STERILITY, 2009, 92 (01) : 226 - 230
  • [26] Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome
    Bosch, E
    Valencia, W
    Escudero, E
    Crespo, J
    Simón, C
    Remohi, J
    Pellicer, A
    FERTILITY AND STERILITY, 2003, 80 (06) : 1444 - 1449
  • [27] Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial
    Kolibianakis, Efstratios M.
    Venetis, Christos A.
    Kalogeropoulou, Lydia
    Papanikolaou, Evangelos
    Tarlatzis, Basil C.
    FERTILITY AND STERILITY, 2011, 95 (02) : 558 - 562
  • [28] Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
    Rashidi, Batool Hosein
    Kabodmehri, Roya
    Shariat, Mamak
    Tehraninejad, Ensieh Shahrokh
    Abdollahi, Alireza
    Bagheri, Maryam
    Hagholahi, Fedieh
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2019, 17 (03) : 209 - 216
  • [29] Effects of increasing serum luteinizing hormone levels during early phase of the gonadotropin-releasing hormone antagonist protocol on clinical outcomes of the in vitro fertilization cycle
    Huang, Qianwen
    Nong, Yingqi
    Zhang, Xiqian
    Huang, Li
    Tang, Ting
    Huang, Ju
    Liu, Fenghua
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (02) : 135 - 139
  • [30] IN VITRO FERTILIZATION OUTCOMES IN PCOS PATIENTS WITH ELEVATED BASAL LUTEINIZING HORMONE DURING A GONADOTROPIN-RELEASING HORMONE ANTAGONIST CYCLE: A RETROSPECTIVE COHORT STUDY.
    Xiao, Shan
    Zhang, Hongzhan
    Mo, Meilan
    Zeng, Yong
    FERTILITY AND STERILITY, 2021, 116 (03) : E369 - E369
12345